Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection
- 31 July 2004
- journal article
- Published by Elsevier BV in Journal of Hospital Infection
- Vol. 57 (3), 209-216
- https://doi.org/10.1016/j.jhin.2004.03.022
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Global Impact of Drug ResistanceClinical Infectious Diseases, 2003
- Microbial Resistance: Bacteria and MoreClinical Infectious Diseases, 2003
- Control‐Group Selection Importance in Studies of Antimicrobial Resistance: Examples Applied toPseudomonas aeruginosa,Enterococci, andEscherichia coliClinical Infectious Diseases, 2002
- Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?Clinical Infectious Diseases, 2002
- Methodological Principles of Case-Control Studies That Analyzed Risk Factors for Antibiotic Resistance: A Systematic ReviewClinical Infectious Diseases, 2001
- Risk Factors for Recovery of Ampicillin-Sulbactam-Resistant Escherichia coli in Hospitalized PatientsAntimicrobial Agents and Chemotherapy, 2000
- Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosaMicrobiology, 1999
- CDC Definitions for Nosocomial Infections, 1988American Review of Respiratory Disease, 1989
- An Assessment of Patient-Related Economic Costs in an Outbreak of SalmonellosisNew England Journal of Medicine, 1978
- Gram-Negative BacteremiaArchives of Internal Medicine, 1962